35. Pemphigus Clinical trials / Disease details

Clinical trials : 98 / Drugs : 126 - (DrugBank : 41) / Drug target genes : 23 - Drug target pathways : 168

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04400994 (ClinicalTrials.gov)	June 20, 2020	27/4/2020	IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus	The Use of IVIG in Combination With Rituximab VS Rituximab as the First Line Treatment of Pemphigus	Pemphigus	Drug: Rituximab;Other: IVIg	The University of Hong Kong	NULL	Recruiting	18 Years	70 Years	All	20	Phase 2	Hong Kong
2	NCT00483119 (ClinicalTrials.gov)	April 2007	5/6/2007	Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus	Phase 2 Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus	Pemphigus Vulgaris	Drug: intravenous immunoglobulin;Drug: cyclophosphamide	New York University School of Medicine	NULL	Terminated	18 Years	85 Years	All	9	Phase 2	United States